217 related articles for article (PubMed ID: 25212851)
21. Association between dopamine transporter gene (
Avsar O; Derinoz N; Yilmaz F; Yilmaz M; Gorkem U
Gynecol Endocrinol; 2022 Jul; 38(7):573-576. PubMed ID: 35536100
[TBL] [Abstract][Full Text] [Related]
22. The role of the dopamine transporter DAT1 genotype on the neural correlates of cognitive flexibility.
Garcia-Garcia M; Barceló F; Clemente IC; Escera C
Eur J Neurosci; 2010 Feb; 31(4):754-60. PubMed ID: 20141527
[TBL] [Abstract][Full Text] [Related]
23. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.
Fallon SJ; Smulders K; Esselink RA; van de Warrenburg BP; Bloem BR; Cools R
Neuropsychologia; 2015 Oct; 77():42-51. PubMed ID: 26239947
[TBL] [Abstract][Full Text] [Related]
24. Dopamine transporter genotype modulates brain activity during a working memory task in children with ADHD.
Pineau G; Villemonteix T; Slama H; Kavec M; Balériaux D; Metens T; Baijot S; Mary A; Ramoz N; Gorwood P; Peigneux P; Massat I
Res Dev Disabil; 2019 Sep; 92():103430. PubMed ID: 31306870
[TBL] [Abstract][Full Text] [Related]
25. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
[TBL] [Abstract][Full Text] [Related]
26. Compensatory fronto-parietal hyperactivation during set-shifting in unmedicated patients with Parkinson's disease.
Gerrits NJ; van der Werf YD; Verhoef KM; Veltman DJ; Groenewegen HJ; Berendse HW; van den Heuvel OA
Neuropsychologia; 2015 Feb; 68():107-16. PubMed ID: 25576907
[TBL] [Abstract][Full Text] [Related]
27. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans.
Holst SC; Bersagliere A; Bachmann V; Berger W; Achermann P; Landolt HP
J Neurosci; 2014 Jan; 34(2):566-73. PubMed ID: 24403155
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
30. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
[TBL] [Abstract][Full Text] [Related]
31. Indirect association of DAT1 genotype with executive function through white matter volume in orbitofrontal cortex.
Chung T; Ferrell R; Clark DB
Psychiatry Res; 2015 Apr; 232(1):76-83. PubMed ID: 25704259
[TBL] [Abstract][Full Text] [Related]
32. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
Nombela C; Rowe JB; Winder-Rhodes SE; Hampshire A; Owen AM; Breen DP; Duncan GW; Khoo TK; Yarnall AJ; Firbank MJ; Chinnery PF; Robbins TW; O'Brien JT; Brooks DJ; Burn DJ; ; Barker RA
Brain; 2014 Oct; 137(Pt 10):2743-58. PubMed ID: 25080285
[TBL] [Abstract][Full Text] [Related]
33. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
34. Working memory plasticity modulated by dopamine transporter genotype.
Brehmer Y; Westerberg H; Bellander M; Fürth D; Karlsson S; Bäckman L
Neurosci Lett; 2009 Dec; 467(2):117-20. PubMed ID: 19819301
[TBL] [Abstract][Full Text] [Related]
35. The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease.
Dos Santos EUD; Sampaio TF; Tenório Dos Santos AD; Bezerra Leite FC; da Silva RC; Crovella S; Asano AGC; Asano NMJ; de Souza PRE
J Pharm Pharmacol; 2019 Feb; 71(2):206-212. PubMed ID: 30353564
[TBL] [Abstract][Full Text] [Related]
36. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
37. Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease.
Nagano-Saito A; Habak C; Mejía-Constaín B; Degroot C; Monetta L; Jubault T; Bedetti C; Lafontaine AL; Chouinard S; Soland V; Ptito A; Strafella AP; Monchi O
Neurobiol Aging; 2014 Jan; 35(1):223-31. PubMed ID: 23932879
[TBL] [Abstract][Full Text] [Related]
38. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
[TBL] [Abstract][Full Text] [Related]
39. Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and after unilateral posteroventral pallidotomy.
Jahanshahi M; Rowe J; Saleem T; Brown RG; Limousin-Dowsey P; Rothwell JC; Thomas DG; Quinn NP
J Cogn Neurosci; 2002 Feb; 14(2):298-310. PubMed ID: 11970793
[TBL] [Abstract][Full Text] [Related]
40. Abnormal fronto-striatal functional connectivity in Parkinson's disease.
Xu J; Zhang J; Wang J; Li G; Hu Q; Zhang Y
Neurosci Lett; 2016 Feb; 613():66-71. PubMed ID: 26724369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
